We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+9.37%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$29.8B
AUM Growth
+$2.61B
Cap. Flow
+$204M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.49%
Holding
319
New
30
Increased
92
Reduced
86
Closed
4

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$62.9M
2
OGN icon
Organon & Co
OGN
+$57.9M
3
MAR icon
Marriott International
MAR
+$50.4M
4
MSFT icon
Microsoft
MSFT
+$48.5M
5
NOW icon
ServiceNow
NOW
+$38.6M

Top Sells

Rank Stock Value
1
CB icon
Chubb
CB
+$75.9M
2
ABBV icon
AbbVie
ABBV
+$59.9M
3
AAPL icon
Apple
AAPL
+$28.9M
4
MO icon
Altria Group
MO
+$19.2M
5
MRK icon
Merck
MRK
+$13M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 20.63%
3 Consumer Staples 18.28%
4 Communication Services 11.3%
5 Healthcare 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOW icon
176
Dow Inc
DOW
$21.9B
$1.47M ﹤0.01%
23,261
WWE
177
DELISTED
World Wrestling Entertainment
WWE
$1.45M ﹤0.01%
25,070
RACE icon
178
Ferrari
RACE
$69.3B
$1.44M ﹤0.01%
7,000
EQR icon
179
Equity Residential
EQR
$24.9B
$1.37M ﹤0.01%
+17,817
New +$1.35M
KEX icon
180
Kirby Corp
KEX
$7.01B
$1.35M ﹤0.01%
22,255
LYB icon
181
LyondellBasell Industries
LYB
$20B
$1.35M ﹤0.01%
+13,114
New +$1.42M
NNN icon
182
NNN REIT
NNN
$9.04B
$1.25M ﹤0.01%
+26,742
New +$1.25M
AIG icon
183
American International
AIG
$41.7B
$1.25M ﹤0.01%
26,256
+19,361
+281% +$957K
BAX icon
184
Baxter International
BAX
$13.5B
$1.22M ﹤0.01%
15,144
GPC icon
185
Genuine Parts
GPC
$17.1B
$1.22M ﹤0.01%
+9,633
New +$1.21M
DE icon
186
Deere & Co
DE
$160B
$1.22M ﹤0.01%
3,446
+250
+8% +$91.3K
TMO icon
187
Thermo Fisher Scientific
TMO
$213B
$1.2M ﹤0.01%
2,372
+813
+52% +$384K
TSLA icon
188
Tesla
TSLA
$1.23T
$1.2M ﹤0.01%
5,274
+3,024
+134% +$656K
CADE
189
DELISTED
Cadence Bank
CADE
$1.18M ﹤0.01%
41,800
WU icon
190
Western Union
WU
$1.99B
$1.18M ﹤0.01%
+51,152
New +$1.27M
APH icon
191
Amphenol
APH
$198B
$1.17M ﹤0.01%
34,136
+128
+0.4% +$4.32K
TPR icon
192
Tapestry
TPR
$30.8B
$1.15M ﹤0.01%
26,441
IDXX icon
193
Idexx Laboratories
IDXX
$44.1B
$1.11M ﹤0.01%
1,754
HBI
194
DELISTED
Hanesbrands
HBI
$1.1M ﹤0.01%
+59,117
New +$1.17M
CNQ icon
195
Canadian Natural Resources
CNQ
$99.4B
$1.1M ﹤0.01%
61,942
VTRS icon
196
Viatris
VTRS
$20.4B
$1.09M ﹤0.01%
76,024
-1,376
-2% -$19.9K
BMY icon
197
Bristol-Myers Squibb
BMY
$133B
$1.07M ﹤0.01%
15,989
-1,142
-7% -$74.5K
CCEP icon
198
Coca-Cola Europacific Partners
CCEP
$48.3B
$1.07M ﹤0.01%
18,000
VFC icon
199
VF Corp
VFC
$5.63B
$1.06M ﹤0.01%
12,942
+4,547
+54% +$379K
NVDA icon
200
NVIDIA
NVDA
$4.86T
$1.06M ﹤0.01%
+52,800
New +$846K

Similar funds

Fayez Sarofim & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Fayez Sarofim & Co held 319 positions worth $29.8B, up 9.6% from $27.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q2 2021 filing shows 30 new, 92 increased, 86 reduced and 4 closed positions. Its largest new stake was Organon & Co: 1,758,918 shares worth $53.2M. The largest sale was Chubb, an estimated $75.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q2 2021 buy was Organon & Co: 1,758,918 shares worth $53.2M.
  • Fayez Sarofim & Co added most to Procter & Gamble in Q2 2021, an estimated $62.9M increase.
  • Fayez Sarofim & Co's biggest Q2 2021 reduction was Chubb, cutting an estimated $75.9M.
  • Fayez Sarofim & Co fully exited US Bancorp in Q2 2021, selling an estimated $359K.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $29.8B portfolio in Q2 2021.
  • Fayez Sarofim & Co opened 30 new positions and closed 4 in Q2 2021.
  • Fayez Sarofim & Co's portfolio value rose 9.6% quarter-over-quarter to $29.8B.

Based on Fayez Sarofim & Co's 13F filing for Q2 2021, filed 13 Aug 2021.